The Impact of Frailty and Metabolic Syndrome on Mortality Among Older Adults: A Five-Year Prospective Cohort Study


DOĞAN N., AKIN S., AKANDERE BARLAS E., DEVECİ N. Ö., ÖKTEM A. A., AKGÜL Y. S. S., ...Daha Fazla

Metabolic Syndrome and Related Disorders, cilt.23, sa.9, ss.405-413, 2025 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 9
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1177/15578518251371527
  • Dergi Adı: Metabolic Syndrome and Related Disorders
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, MEDLINE
  • Sayfa Sayıları: ss.405-413
  • Anahtar Kelimeler: frailty, metabolic syndrome, mortality, older adults, prospective cohort study
  • Erciyes Üniversitesi Adresli: Evet

Özet

Background: Frailty and metabolic syndrome (MetS) are common conditions in older adults and may share overlapping pathophysiological pathways that impact mortality. Objectives: We aimed to investigate the effect of frailty and MetS on mortality the older adults. Methods: This study included 1100 outpatients aged ≥60 years. We followed the participants for five years, during which 13.2% of them died. The status of MetS was assessed using the criteria established by the National Cholesterol Education Program Third Adult Treatment Panel. We evaluated frailty using the FRAIL scale. Results: Mean age was 71.57 ± 7.09 years. The frail group had a significantly higher mean age (73.13 ± 7.75) compared to the nonfrail (70.20 ± 6.23) and prefrail (70.86 ± 6.73) groups (P < 0.001). In all three groups, women made up the majority, but in the frail group (76.9%), there were significantly more women than other groups (P < 0.001). MetS was more prevalent in prefrail and frail groups compared to those who were nonfrail (nonfrail: %59.1, prefrail: %71, frail: %70.2) (P = 0.010). The frail group showed a higher frequency of cognitive impairment, depressive mood, malnutrition, and dependency. The overall mortality rate for the sample was 13.2%, as anticipated, the frail group has a significantly higher mortality rate (23.4%) compared to the other two groups (nonfrail: 5.3%, prefrail: 10.2%) (P < 0.001). The Cox proportional hazards model indicated that the frail group demonstrated an increased mortality risk over five years, even after adjusting for age, sex, and metabolic disorders (hazard ratio: 4.44, 95% confidence interval = 2.19-9.02, P < 0.001). Conclusions: Frailty was a more accurate predictor of mortality than MetS, regardless of age.